Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Airway Secretome Responses to Ozone and Diesel: ALI Model In

    2026-05-11

    Deciphering Airway Epithelial Secretome Alterations Induced by Air Pollutants: Evidence from an Air–Liquid Interface Model

    Study Background and Research Question

    Air pollution is a major global health threat, with chronic exposure driving morbidity and mortality in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) (source: paper). Ozone (O3) and diesel exhaust particles (DEP) are prominent urban pollutants known to damage airway epithelial barriers, yet the mechanistic underpinnings of mixed exposures—closely reflecting real-world inhalation scenarios—have remained elusive. Notably, while individual pollutant effects are relatively well-studied, the cellular pathways activated when O3 and DEP are encountered together have not been fully defined. This gap impedes the development of targeted strategies to counteract the compounded effects of complex air pollution. The referenced study aimed to map shared and divergent molecular pathways activated by O3 and DEP in airway epithelial cells. Leveraging a physiologically relevant air–liquid interface (ALI) model, the investigators sought to uncover: (i) immediate barrier function impairments, (ii) the spectrum of inflammatory mediators (alarmins) released, and (iii) the secretome-level signaling changes underlying these responses.

    Key Innovation from the Reference Study

    A principal methodological advance in this work is the use of the ALI model with polarized Calu-3 airway epithelial monolayers. Unlike traditional submerged cultures, the ALI system mimics in vivo exposure and epithelial differentiation, enabling acute, physiologically relevant pollutant challenge (source: paper). This approach provided a more accurate lens for assessing how airway epithelium initially senses and responds to O3 and DEP. Moreover, the study integrates comprehensive secretome profiling via label-free liquid chromatography–tandem mass spectrometry (LC–MS/MS), alongside conventional barrier function assays and gene/protein expression analyses. This multi-layered strategy allowed the researchers to track not only structural and inflammatory outcomes but also the convergence of downstream molecular pathways—such as Wnt signaling and antigen processing—following pollutant exposure.

    Methods and Experimental Design Insights

    Polarized Calu-3 airway epithelial cells were cultured at the ALI to establish functional tight (TJs) and adherens junctions (AJs), critical for barrier integrity. After differentiation, monolayers were acutely exposed to non-cytotoxic concentrations of O3 or DEP (source: paper). Key methodological elements included:
    • Barrier integrity assessment: Transepithelial electrical resistance (TEER) and FITC-dextran permeability assays quantified paracellular leakage.
    • Gene and protein expression: Quantitative PCR measured mRNA levels of key tight junction proteins and alarmin cytokines (IL-25, IL-33, TSLP), while immunofluorescence localized tight junction proteins at the cell–cell interface.
    • Secretome analysis: Label-free LC–MS/MS profiled secreted proteins, enabling pathway enrichment analysis to reveal convergent cellular responses.
    The study design allowed for direct comparison of pollutant-specific and shared effects on epithelial function and secreted signaling networks.

    Protocol Parameters

    • assay | TEER measurement | Ω·cm2 | assesses epithelial barrier integrity | reflects tight junction function | paper
    • assay | FITC-dextran permeability | μg/mL | quantifies paracellular leak | indicates loss of barrier selectivity | paper
    • assay | qPCR for cytokines and TJs | fold change | monitors transcriptional response | tracks inflammatory and barrier-related gene regulation | paper
    • assay | LC–MS/MS secretome profiling | n/a | identifies and quantifies secreted proteins | enables pathway enrichment analysis | paper
    • assay | WST-8 or tetrazolium salt-based cell viability assay | 0.5–1 h workflow | verifies non-cytotoxic exposure conditions | recommended for rapid screening | workflow_recommendation

    Core Findings and Why They Matter

    The study demonstrates that both O3 and DEP impair airway epithelial barrier function, as evidenced by decreased TEER and increased FITC-dextran permeability. These structural insults are accompanied by robust upregulation of alarmin cytokines (IL-25, IL-33, TSLP), which are implicated in initiating and propagating airway inflammation (source: paper). Crucially, secretome profiling revealed a convergence in downstream response pathways despite pollutant-specific upstream damage patterns. Both O3 and DEP exposures led to:
    • Activation of Wnt signaling: A pathway known to regulate cellular repair, proliferation, and differentiation in the airway epithelium.
    • Induction of antigen processing and presentation: Suggesting enhanced immune surveillance or priming in response to pollutant-induced injury.
    These shared mechanisms underscore the potential for overlapping therapeutic targets in mixed-pollutant exposure scenarios and provide a mechanistic explanation for the exacerbation of airway diseases in polluted environments.

    Comparison with Existing Internal Articles

    Several internal resources have discussed the application of advanced cell proliferation and cytotoxicity assays—especially the Cell Counting Kit-8 Plus—in toxicological and mechanistic respiratory research:
    • The article "Cell Counting Kit-8 Plus: Advancing WST-8 Based Cell Viab..." highlights the rapid and sensitive quantification of cell proliferation and cytotoxicity enabled by WST-8 chemistry, supporting toxicological workflows similar to those in the reference study (internal article).
    • "Applied Cell Counting Kit-8 Plus: Workflows, Sensitivity & Solutions" provides detailed protocol parameters and troubleshooting guidance for WST-8 cell proliferation assays, which are well-suited for screening pollutant-induced cytotoxicity without compromising specificity (internal article).
    • For oncology-focused applications, "Cell Counting Kit-8 Plus: Precision Tetrazolium Salt Assay in Oncology" demonstrates robust dehydrogenase activity measurement, a principle directly applicable to airway epithelial models when validating non-cytotoxic pollutant dosages (internal article).
    These articles reinforce the importance of reliable, high-sensitivity tetrazolium salt assays—such as CCK-8 Plus—for ensuring that experimental pollutant exposures are within non-lethal ranges, as was critical in the ALI study design.

    Limitations and Transferability

    While the ALI model provides superior physiological relevance compared to submerged cultures, it remains an in vitro system, lacking the full complexity of multicellular airway tissue and immune cell cross-talk present in vivo. The use of a single cell line (Calu-3) may also limit the generalizability of findings across different airway epithelial subtypes. Exposures were acute and at non-cytotoxic levels; thus, chronic or repeated exposures and their cumulative impact were not addressed (source: paper). Nevertheless, the identification of convergent downstream pathways—specifically Wnt signaling and antigen presentation—suggests that these mechanisms might be conserved across airway models and perhaps in vivo, warranting further translational and clinical investigation.

    Research Support Resources

    For researchers aiming to replicate or extend ALI-based airway toxicity workflows, rapid and sensitive assessment of cell viability and cytotoxicity is essential. The Cell Counting Kit-8 (CCK-8) Plus (SKU K2268) offers an improved WST-8-based tetrazolium salt assay platform, supporting quantitative cell proliferation and dehydrogenase activity measurement within 0.5–1 hour. This assay is optimized for diverse cell types and can facilitate high-throughput screening of pollutant effects, as well as validation of non-cytotoxic dose ranges (source: product_spec | workflow_recommendation). APExBIO provides detailed protocols and long-term storage guidance for the kit, ensuring reproducibility in airway toxicology and secretome research.